Does self-administration of a quality of life index for inflammatory bowel disease change the results?

Journal of Clinical Epidemiology

Volumn 49, Issue 10, 1996, Pages 1177-1185

  Irvine, E J ^a   Feagan, B G ^b   Wong, C J ^c  

^a MCMASTER UNIVERSITY   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Colitis ulcerative; Crohn's disease; Health status instrument; Index of health; Quality of life; Questionnaire; Self administration

Indexed keywords

ADULT; ARTICLE; CORRELATION FUNCTION; CROHN DISEASE; DISEASE ACTIVITY; ERROR; EXPERIENCE; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NURSE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCORING SYSTEM; TIME; ULCERATIVE COLITIS;

EID: 0030273112     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(96)00136-9     Document Type: Article

References (20)

1. 1. Kirsner JB. Problems in the differentiation of ulcerative colitis and Crohn's disease of the colon: The need for repeated diagnostic evaluation. (Editorial.) Gastroenterology 1975; 68: 187-191.
2. 2. Irvine EJ. A quality of life index for inflammatory bowel disease. Can J Gastroenterol 1993; 7: 155-159.
3. 3. Guyatt GH, Mitchell A, Irvine EJ, Singer J, Williams BA, Goodacre R, Tompkins C. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989; 96: 804-810.
4. 4. Irvine EJ, Feagan B, Rochon J, Archambault A, Fedorak RN, Groll A, Kinnear D, Saibil F, McDonald JWD. Quality of life: A valid and reliable measure of outcome for clinical trials in inflammatory bowel disease. Gastroenterology 1994; 106: 287-296.
5. 5. Hay JW, Hay AR. Inflammatory bowel disease: Cost of illness. J Clin Gastroenterology 1992; 14: 309-317.
6. 6. MacIntyre IMC. Tribulations for clinical trials. Br Med J 1991; 1099-1100.
7. 7. Edwards FC, Truelove SC. The course and prognosis of ulcerative colitis. II. Long term prognosis. Gut 1963; 4: 309-315.
8. 8. Malchow H, Brandes JW, Goebell H, Elms H, Sommer H, Hedensky. European Cooperative Crohn's Disease Study: Results of drug treatment. Gastroenterology 1984; 86: 249-266.
9. 9. Feagan B, McDonald JWD, Rochon J, Archambault A, Fedorak RN, Groll A, Kinnear D, Saibil F, Irvine EJ. Chronic low dose cyclosporine in the treatment of Crohn's disease. N Engl J Med 1994; 330; 1846-1851.
10. 10. Best WR, Becktel JM, Singleton J W, Kern R. Development of a Crohn's disease activity index. Gastroenterology 1976; 70: 439-444.
11. 11. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 1979; 77: 843-846.
12. 12. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980; 1: 514-515.
13. 13. Sutherland LR, Martin F, Greer S, Robinson M, Greenberger N, Saibil F, Martin T, Sparr J, Prokipchuk E, Borgen L. 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis and proctitis. Gastroenterology 1987; 92: 1894-1898.
14. 14. Deyo RA, Diehr P, Patrick DL. Reproducibility and responsiveness of health status measures. Controlled Clin Trials 1991; 12: 142S-158S.
15. 15. Martin F, Sutherland L, Beck IT, Anderson AH, Williams CN, Saibil F, Barrowman J, Lemire S. Oral 5ASA versus prednisone in short term treatment of Crohn's disease: A multicentre controlled trial. Can J Gastroenterol 1990; 4: 452-457.
16. 16. Greenberg GR, Feagan BG, Martin FM, Sutherland LR, Thomson ABR, Williams CN, Nilsson LG, Persson T, and the Canadian Inflammatory Bowel Disease Study Group. Oral budesonide for active Crohn's disease. N Engl J Med 1994; 331: 836-841.
17. 17. Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, Greenberg GR, Gillies R, Hopkins M, Hanauer SB, McDonald JWD, for the North American Crohn's Study Group Investigators. Methotrexate for the treatment of Crohn's disease. N Engl J Med 1995; 332: 292-297.
18. 18. Irvine EJ, Donnelly M. Quality of life is comparably impaired in patients with ulcerative colitis and irritable bowel syndrome. Gastroenterology 1994; 106: A517.
19. 19. Drossman DA, Patrick DL, Mitchell CM, Murp EA, Zagomi EA, Appelbaum MI. Health related quality of life in IBD: Functional status and patient worries and concerns. Digest Dis Sci 1989; 34: 1379-1386.
20. 20. Irvine EJ. Finding the right index for IBD. In: Sutherland LR, Collins SM, Martin F, McLeod R, Targan SR, Wallace JL, Williams CN, eds. Inflammatory Bowel Disease Therapy: Basic Research, Clinical Implications and Trends in Therapy. Lancaster, UK: Kluwer Academic Publishers; 1994: 191-196.